We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug Products
    • Books
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Subscription Newsletters
    • Free Newsletters
    • Webinar Training Pass
    • eCFR and Guidances
  • Device Products
    • Books
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Subscription Newsletters
    • Free Newsletters
    • Webinar Training Pass
    • eCFR and Guidances
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Store » Drug Products » What We’ve Learned Since Scott Gottlieb Was Confirmed - Webinar Recording/Transcript

Other Options

Audio Recording/Transcript - Sept. 14, 2017

$287.00

Audio Recording/Transcript - Sept. 14, 2017

$258.00

Audio Recording/Transcript - Sept. 14, 2017

$244.00

Audio Recording/Transcript - Sept. 14, 2017

$230.00

Audio Recording/Transcript - Sept. 14, 2017

$215.00

What We’ve Learned Since Scott Gottlieb Was Confirmed - Webinar Recording/Transcript

$287.00
Drug Products

Product Details

What We’ve Learned Since Scott Gottlieb Was Confirmed

FDA’s new Commissioner, Dr. Scott Gottlieb, isn’t letting grass grow beneath his feet. With a new occupant in the White House and a new philosophy in Congress, change is in the air. And this is only the beginning.

FDAnews has assembled a standout panel — five top experts, four of them ex-FDAers — to bring their insights to bear on how the Gottlieb FDA will impact your products and programs. In this first-of-four installments, expect a glimpse of:

  • What the Trump-Gottlieb FDA is likely to continue and what will likely change...
  • What’s going on behind closed doors — unannounced priorities Gottlieb & Co. can be expected to cook up...
  • Guidances, regulation, enforcement: What lies ahead...
  • Specific, practical guidance to help you prepare, based on Dr. Gottlieb’s record and regulatory inclinations as well as unfolding events...
  • How to plan now to achieve your goals for 2017, 2018 and beyond...

Plan to tune in once a month every month through December to learn more as events unfold in real time. Other installments include:

  • Device Regulation under Gottlieb & Trump
  • Pharmaceutical Regulation under Gottlieb-Trump
  • The FDA Under Gottlieb-Trump and a Look Ahead

Given the fluid nature of events though, panelists are sure to range beyond the topic of the day.

  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell My Personal Information
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Fax 703.538.7676 – Toll free 888.838.5578

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing